IceCure Medical (ICCM) Finished Goods (2020 - 2025)

IceCure Medical (ICCM) has 6 years of Finished Goods data on file, last reported at $549000.0 in Q4 2025.

• Quarterly Finished Goods rose 57.31% year-over-year to $549000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $549000.0 (up 57.31% YoY) and the FY2025 annual result came in at $549000.0, up 57.31% from the prior year.
• Finished Goods rose to $549000.0 in Q4 2025 per ICCM's latest filing, from $349000.0 in the prior quarter.
• Across five years, Finished Goods topped out at $935000.0 in Q4 2022 and bottomed at $349000.0 in Q4 2024.
• The 5-year median for Finished Goods is $568000.0 (2023), against an average of $639000.0.
• The widest annual swing landed in 2021, when Finished Goods jumped 125.57%; it then slumped 39.25% in 2023.
• Tracing ICCM's Finished Goods over 5 years: stood at $794000.0 in 2021, then increased by 17.76% to $935000.0 in 2022, then sank by 39.25% to $568000.0 in 2023, then slumped by 38.56% to $349000.0 in 2024, then surged by 57.31% to $549000.0 in 2025.
• Per Business Quant, the three latest ICCM Finished Goods figures stand at $549000.0 (Q4 2025), $349000.0 (Q4 2024), and $568000.0 (Q4 2023).

Peer Comparison